Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma.

Qianhan LinXiaoxue MaShunxue HuRui LiXuan WeiBing HanYanhui MaPei-Shu LiuYingxin Pang

Published in: Cancer management and research (2021)

Heterotopic NCL is a potential prognostic biomarker for EC. Inhibiting the distribution of NCL from the nucleus to the cytoplasm and membrane may be a promising therapeutic strategy to improve outcomes in patients with EC with high NCL expression.

Keyphrases

poor prognosis
human health
cell proliferation
signaling pathway
transcription factor
risk assessment
skeletal muscle
binding protein
climate change